OVERVIEW
Chronic inflammatory demyelinating polyneuropathy (CIDP) affects 2 or 3 in 100,000 people and peaks in incidence among those aged 40 to 60 years. CIDP is most likely the result of autoimmune inflammation of peripheral nerves and can present as a monophasic, progressive, or relapsing and remitting disease, causing symmetrical weakness in both proximal and distal muscles. This weakness, along with sensory loss, leads to difficulty walking and hyporeflexia or areflexia. The variability in terms of clinical presentation, pathogenesis, autoantibody profile, disease progression, and response to treatment make CIDP challenging for physicians to diagnose. Delays can lead to axonal loss associated with the progressive demyelination process of the disease. Join Dr Cornblath in this live-streamed video webcast as he discusses the 2021 updates to the CIDP diagnosis and management guidelines with clinical, electrophysiological, immunological, and genetic characteristics of the CIDP variants to help increase diagnostic accuracy for affected patients.
GOAL STATEMENT
The goal of this activity is to increase the ability of learners to recognize CIDP in a timely manner.
LEARNING OBJECTIVES
Upon completion of this activity, participants will: Have increased knowledge regarding the [LIST][ITEM]Necessary tests involved in the diagnosis of a patient with CIDP[/LIST] Have greater competence related to [LIST][ITEM]Accurately diagnosing CIDP [/LIST]
ACCREDITATION STATEMENT
In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. [JALOGO] [MEDSCAPE]
[bold]For Physicians[/bold] Medscape, LLC designates this live activity for a maximum of 0.5 [italic][bold]AMA PRA Category 1 Credits[/bold][/italic]™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Supported by an independent educational grant from [bold]CSL Behring[/bold].